Erythropoietin - Albumin Platelet-rich Fibrin in Transcrestal Sinus Lifting With Simultaneous Implant Placement

ConditionSinus Lifting
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-60
SponsorAlexandria University

About this trial

Background: Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence trans crestal sinus lifting with albumin platelet rich plasma.

Aim of the study: To compare between erythropoietin and albumin platelet rich fibrin transcrestal sinus lifting versus albumin platelet rich fibrin transcrestal sinus lifting using piezoelectric device in patients with atrophic maxilla.

Methods: This study will be carried out as a randomized

Eligibility criteria

Qualifiers

Residual bone height not less than 5 mm measured from crestal bone to sinus floor.

Both genders.

Good oral hygiene

No previous surgery or radiation treatment on the maxillary sinus

Disqualifiers

Recent radiation therapy in maxilla.

Uncontrolled systemic diseases such as diabetes mellitus.

Heavy smoker (those who smoke ≥ 25 cigarettes a day).

Alcohol abuse.

Trial design

Treatments tested in this trial

  • Erythropoietin and albumin PRF gel + implant placement
  • Albumin PRF gel +implant placement

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators